ProCE Banner Activity

Evaluating Efficacy and Safety of Allo-SCT and Prognostic Value of MRD-Negative CR After 19-28z CAR T-Cell Infusion in Patients With R/R B-Cell ALL

Slideset Download
Conference Coverage
MRD-negative CR following 19-28z CAR T-cell infusion associated with superior OS.

Released: December 18, 2015

Expiration: December 16, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen